AxoGen Cash Flow - Quarterly (NASDAQ:AXGN)

Add to My Stocks
$39.4 $0.9 (2.34%) AXGN stock closing price Mar 21, 2018 (Closing)

The AxoGen cash flow statement is one of the important reports considered by investors doing a fundamental analysis of the company. In simple terms, the cash flow statement measures the cash that has come into the company, and the cash that has gone out during a given period, while the other statements, the income statement and balance sheet, give details about AxoGen profits and AxoGen debt. This statement can tell if a company is running out of money while still being profitable and is useful in AxoGen stock analysis. AxoGen had a negative net income cash flow of $-7.94M till this quarter of 2017 Q3. This report is very useful in measuring the short term viability of a company. AxoGen saw a outflow of $-0.79M from investing activities till 2017 Q3.

View and download details of AxoGen cash flows for latest & last 40 quarters
show more
View Previous Quarters
View Next Quarters
Fiscal year is Jan - Dec2017 Q32017 Q22017 Q12016 Q42016 Q32016 Q22016 Q12015 Q42015 Q3
Net Income Cash Flow
Depreciation Depletion Amortization Cash-Flow---------
Net Increase (Decrease) in Assets Liabilities-3.46M-2.22M-1.25M-1.49M-2.73M-2.17M-1.39M-1.97M-0.8M
Cash From (used in) Discontinued Operations---------
Other Adjustments Net2.67M1.67M-4.14M1.32M--1.9M1.48M
Net Cash from (used by) Operating Activities
Increase (Decrease) in Prop Plant And Equipment-0.61M-0.36M-0.09M-0.96M-0.61M-0.45M-0.4M-0.4M-0.35M
Acquisition Disposition of Subsidiaires---------
Increase (Decrease) in Investments---------
Other Cash Inflow (Outflow) from Investment Activities-0.18M-0.15M-0.08M-0.22M-0.15M-0.09M-0.08M-0.14M-0.09M
Net Cash from (used by) Investment Activities
Issuance (Purchase) of Equity Shares1.08M--18.66M---30.96M30.97M
Issuance (Repayment) of Debt Securities-0.01M-0.01M-0.01M-2.44M-----
Increase (Decrease) in Bank & Other Borrowings-0.02M-0.19M-0.04M------
Payment of Dividends & Other Cash Distributions---------
Other Cash from (used by) Financing Activities-0.02M-0.02M-0.02M------0.01M
Net Cash from (used by) Financing Activities
Effect of Exchange Rate Changes on Cash---------
Net Change in Cash & Cash Equivalents
Cash & Equivalents at Beginning of Year25.9M8.21M20.06M13.9M8.19M1.79M15.76M--
Cash & Equivalents at Year End22.04M23.87M25.91M30.01M16M18.27M20.94M25.9M29.93M
All figures in USD. M: Millions of USD, B: Billions of USD.
View Previous Quarters
View Next Quarters

AxoGen stock comparison chart provides an easy way to compare the stock price with peers along with details of AxoGen stock price history.
The statement of cash flows can be categorized into the following main sections:

  • AxoGen has cash of $22.04M on hand. A healthy amount of cash on hand is necessary for any company. Cash has an opportunity cost associated with it, and too much cash in bank may mean that the firm has no or limited growth plans. Hence its important to track the Net Change in Cash and Cash Equivalents along with the AxoGen stock price.
  • AxoGen decreased its cash from operating activities to $-8.18M till 2017 Q3. Operating activities include production of goods or creating a product or providing a service, and collecting payment for the same from customers. The cash generated from these activities is refered to as cash flow from operating activities.
  • Cash Flow from investment activities: AxoGen used $-0.79M cash due to investment activities. It includes the use of cash outside of normal day to day activities like buying fixed assets, plant and machinery etc.
  • Cash flow from financing activities shows the flow of cash between AxoGen and its owners and creditors and was $1.01M till 2017 Q3. Financing activities allow a company to raise capital, and repay bondholders.

Key Financial Ratios For AxoGen Cash Flow

Quarterly Cash Flow Statements For AxoGen, Inc. Peers

Ventrus Biosciences cash flow, Celator Pharma cash flow, Nevro cash flow, Nuvectra cash flow